Mirtazapine Tablet, Film Coated
Product Images NDC 70518-4322

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-4322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text provides information about Mirtazapine tablets, each containing 15 mg, with a quantity of 30 tablets. The medication should be protected from light and moisture. It is a prescription medication with an NDC number of 70518-4322-00 and is manufactured by Mylan Pharma Inc in Morgantown, WV. The storage directions advise keeping it between 20-25°C (58-77°F) with excursions permitted to 15-30°C (59-86°F). The packaging was done by RemedyRepack Inc. in Indiana, PA. All medication should be kept out of the reach of children. For detailed usage instructions, refer to the package insert. The expiration date and lot number fields are blank in the provided text.*
FDA Label Image

Mirtazapine Structural Formula (Image 04)

Mirtazapine Structural Formula (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.